Broadcast Date: Tuesday, September 13, 2022
from 12:00 pm to 1:00 pm (ET)
Overview:
Health systems have rapidly evolved to adopt convenient, virtual, and customer-centered care services. The goal is to leverage technologies, such as remote patient monitoring (RPM), artificial intelligence (AI)-based processes, and machine learning to aid in smoother and more streamlined healthcare delivery. However, the adoption of digital transformation requires a proper regulatory framework, particularly in monitoring and evaluating results.
While these innovations bring more convenience in delivering healthcare services, they also raise issues on data privacy and health equity. Thus, policymakers are considering stricter regulations to ensure the quality of care.
In this LIVE webcast, healthcare law experts John W. Kaveney (Greenbaum, Rowe, Smith & Davis LLP) and Delphine O’Rourke (Goodwin) will provide a comprehensive discussion of the recent regulatory developments in the healthcare sector. Speakers, among other things, will offer best practices in developing and implementing corporate policies to ensure compliance.
Key issues that will be covered in this course are:
- Healthcare Regulatory Developments
- Leveraging Technology in the Healthcare Sector: Legal Implications
- Challenges and Critical Issues
- Explore Compliance Strategies
- What Lies Ahead
Credit:
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-demand Webcast (CLE)
Prerequisite:
General knowledge of Healthcare Industry
Course Code:
149864
NY Category of CLE Credit:
Area of Professional Practice
Total Credit:
1.0 CLE
How to Claim CLE Credits Per State:
https://knowledgewebcasts.com/how-to-claim-cle-credits-per-state/
CLE State Requirements:
Speaker Panel:
John W. Kaveney, Partner, Healthcare Department
Greenbaum, Rowe, Smith & Davis LLP
John W. Kaveney focuses in healthcare law, representing clients in corporate compliance matters, compliance audits and investigations, and self-disclosure and repayment processes. He provides general legal advice concerning compliance and regulatory matters under state and federal healthcare laws and counsels healthcare clients on information privacy and data security issues, including those arising from information breaches. He also advises on Medicaid and Medicare reimbursement matters and professional licensing and medical staffing concerns. His clients include hospitals and health systems, academic medical centers, individual physicians and physician groups, ambulatory surgery centers, ancillary service providers, medical billing companies, skilled nursing and rehabilitation facilities, behavioral health centers and pharmacies.
He is admitted to practice in New Jersey, New York, and in the U.S. District Court for the District of New Jersey.
Delphine O'Rourke, Partner
Goodwin
Delphine O’Rourke has tackled some of the most difficult problems in healthcare from the C-suite and board rooms of health companies. She is a partner in the firm’s Life Sciences group and a leader of the Women’s Health and Wellness practice. Ms. O’Rourke is a health law subject matter expert, provides strategic guidance, technical expertise and regulatory counsel to clients. Ms. O’Rourke develops and executes regulatory solutions on behalf of entrepreneurs, growth companies, healthcare systems, public companies and investors, and works directly with leadership to leverage her clients’ innovative solutions.
Agenda:
John W. Kaveney, Partner, Healthcare Department
Greenbaum, Rowe, Smith & Davis LLP
and
Delphine O'Rourke, Partner
Goodwin
- Artificial Intelligence Continues to Become More Prevalent In An Evolving Healthcare Sector - The continuing evolution and advancement of artificial intelligence is changing society and is being integrated more and more into the healthcare industry. This evolution provides a new and exciting tool for healthcare administrators and clinicians, but also presents challenges for regulators seeking to ensure there is sufficient oversight of this new technology.
- Patient Centered Care and the Movement Toward Empowering Individuals - With the ongoing implementation of the Cures Act Final Rule, the government is continuing to push for greater interoperability and transparency so that individuals play a greater role in their care and have greater access to their health information. However, with greater access comes increased risks regarding privacy and security of protected health information that regulators must continue to anticipate.
- The Ongoing Efforts to Expand Transparency in Healthcare Services - The federal No Surprises Act went into effect on January 1, 2022 and became the latest effort by the federal government to promote price transparency with the ultimate goal of reducing healthcare costs and spending. While its impact on patient conduct and its success in achieving its goals remain uncertain, healthcare providers must adapt and be prepared to satisfy this new area of regulatory oversight.
- Key Regulatory Considerations in a Post-Roe World – On June 24, 2022, the United States Supreme Court of the United States issued its decision in Dobbs v. Jackson Women’s Health Organization, thereby overturning Roe v. Wade. The decision overturned 50 years of legal precedent and protection of a woman’s right to privacy in choosing to abort a pregnancy prior to the point of viability. While all of the regulatory implications of a post-Roe world won’t be known for years, there are key regulatory considerations around the delivery of reproductive and family planning services, women’s health and wellness services and healthcare generally.
- Life After the Public Health Emergency – On July 15, 2022, the United States Department of Health and Human Services once again extended the Covid-19 public health emergency, which was originally declared in January 2020 and has been repeatedly renewed. There is ongoing uncertainty and complexity around the regulatory framework that will exist once the Public Health Emergency eventually ends and the impact on Medicaid coverage, the rapid adoption of telehealth and the myriad COVID waivers.
- Areas to watch in 2022-2023: There is no indication that the frantic pace of regulatory changes in the health space will slow down over the next several years. There are three areas in particular that will definitely be important to track including the future of telemedicine reimbursement, enforcement of electronic prescribing of controlled substances (EPCS) requirements and efforts to roll back the Affordable Care Act.
Date & Time:
Tuesday, September 13, 2022
12:00 pm to 1:00 pm (ET)
Who Should Attend:
- Chief Information Officers
- Chief Information Security Officers
- Chief Security Officers
- Chief Technology Officers
- Chief Medical Officers
- Chief Nursing Officers
- VPs and Directors of IT
- Medical Directors
- Directors of Health Information Management
- Medical Records Directors
- Healthcare Attorneys/Consultants
- Legal and Compliance Executives
- General/In-house Counsel from Healthcare Industry
- Top-Level Executives
SPEAKERS
Join Over 150,000 Professionals Empowering Their Careers
Learn anywhere from over 1800+ live and recorded CLE CPE & Technology webcasts.
